Published in Diabet Med on November 01, 1994
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
Glycated haemoglobin and metabolic control of diabetes mellitus: external versus locally established clinical targets for primary care. BMJ (1995) 2.35
The cost of diabetes Type II in Europe: the CODE-2 Study. Diabetologia (2002) 1.29
Self monitoring of blood glucose in type 2 diabetes. BMJ (2007) 1.08
Benefits of tight blood pressure control in diabetic patients with hypertension: importance of early and sustained implementation of effective treatment strategies. Diabetes Care (2011) 1.05
Controlling glucose and blood pressure in type 2 diabetes. BMJ (2000) 0.83
Does self monitoring of blood glucose as opposed to urinalysis provide additional benefit in patients newly diagnosed with type 2 diabetes receiving structured education? The DESMOND SMBG randomised controlled trial protocol. BMC Fam Pract (2012) 0.79
Targets for glycated haemoglobin. Targets are suggestions to be modified. BMJ (1995) 0.75
A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM) by the European NIDDM Policy Group. Diabet Med (1995) 0.75
Estimation of blood glucose levels by people with diabetes: a cross-sectional study. Br J Gen Pract (2005) 0.75
Pharmacoeconomics of diabetes surveillance and detection programmes. Pharmacoeconomics (1995) 0.75
The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. J Biol Chem (1971) 3.52
The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. 3. Binding of glucagon: method of assay and specificity. J Biol Chem (1971) 3.13
Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med (1988) 2.27
[Endocrine disorders in adolescents and young adults]. Tidsskr Nor Laegeforen (1993) 2.02
With the IDF into the 1990s: a European perspective. Diabet Med (1990) 1.91
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care (1997) 1.84
Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care (1999) 1.82
Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med (1992) 1.80
The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon. J Biol Chem (1971) 1.68
Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet (1993) 1.68
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia (1995) 1.63
The metabolic syndrome in the West Bank population: an urban-rural comparison. Diabetes Care (2001) 1.63
Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer (1994) 1.59
Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med (1993) 1.51
Obesity in a rural and an urban Palestinian West Bank population. Int J Obes Relat Metab Disord (2003) 1.50
Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia (1995) 1.48
Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med (1998) 1.43
Severe or life-threatening hypoglycemia in insulin pump treatment. Diabetes Care (1994) 1.40
Changes in brainstem auditory evoked potentials during insulin-induced hypoglycaemia in type 1 diabetic patients. Diabet Med (1991) 1.39
[New diagnostic criteria for diabetes mellitus--why?]. Tidsskr Nor Laegeforen (2000) 1.37
The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. VI. Evidence for a role of membrane lipids. J Biol Chem (1971) 1.36
Obesity and selected co-morbidities in an urban Palestinian population. Int J Obes Relat Metab Disord (2001) 1.35
Exercise-induced fall of blood glucose in insulin-treated diabetics unrelated to alteration of insulin mobilization. Diabetes (1979) 1.33
Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain (1988) 1.28
The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications (1992) 1.27
Sandostatin LAR in acromegalic patients: long-term treatment. J Clin Endocrinol Metab (1997) 1.26
Inactivation of glucagon by plasma membranes of rat liver. J Biol Chem (1972) 1.20
Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost (1991) 1.19
Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia (1977) 1.17
Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes (1997) 1.13
Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes (1999) 1.13
Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care (1991) 1.13
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest (1990) 1.11
Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiatry (1988) 1.06
Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol (1994) 1.05
Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration. Horm Metab Res (1980) 1.04
Noninvasive blood glucose sensors based on near-infrared spectroscopy. Artif Organs (1994) 1.04
Dietary-induced hypertrophic--hyperplastic obesity in mice. J Lipid Res (1974) 1.04
Glucose as a regulator of insulin-sensitive hexose uptake in 3T3 adipocytes. J Biol Chem (1985) 1.03
Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes Relat Metab Disord (1992) 1.03
Management of type 2 diabetes: a challenge for patient and physician. Patient Educ Couns (2000) 1.03
[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01
Nutritional intake of 2868 IDDM patients from 30 centres in Europe. EURODIAB IDDM Complications Study Group. Diabetologia (1996) 1.01
Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia (1997) 1.00
Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients. Metabolism (1996) 0.99
Activation of the Ras/mitogen-activated protein kinase signaling pathway alone is not sufficient to induce glucose uptake in 3T3-L1 adipocytes. Mol Cell Biol (1994) 0.98
Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation (1993) 0.97
Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. Diabetes Care (2000) 0.97
Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes (1997) 0.96
Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM. Horm Metab Res (1997) 0.95
Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry (1990) 0.95
The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med (1993) 0.94
Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete Metab (1993) 0.94
Blood amine acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism (1978) 0.93
Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes (1988) 0.92
HLA antigens and immunoresponsiveness to insulin in insulin-dependent diabetes mellitus. Tissue Antigens (1976) 0.92
The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetes. Klin Wochenschr (1988) 0.91
Self monitoring of glucose by people with diabetes. Self monitoring improves quality of life and prognosis of people with diabetes. BMJ (1997) 0.91
Glucose metabolism in perfused skeletal muscle. Demonstration of insulin resistance in the obese Zucker rat. Biochem J (1979) 0.91
Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG). Eur J Clin Pharmacol (1986) 0.91
Diabetes mellitus in an urban Palestinian population: prevalence and associated factors. East Mediterr Health J (2003) 0.90
Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. WHO Drug Utilization Research Group (DURG). Eur J Clin Pharmacol (1986) 0.90
Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Diabete Metab (1993) 0.89
Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects. Diabetologia (1991) 0.89
Outcome of pregnancies in diabetic mothers in Norway 1967-1976. Diabetologia (1980) 0.88
Fluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients. Int J Obes Relat Metab Disord (1992) 0.88
A leucine to proline mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface. Biochemistry (1991) 0.88
A mutation in the insulin receptor that impairs proreceptor processing but not insulin binding. J Biol Chem (1994) 0.88
Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues. Diabetologia (1991) 0.88
Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia (1991) 0.88
Cardiovascular effects of glucagon. Acta Med Scand (1971) 0.88
Cerebral glucose metabolism in type 1 diabetic patients. Diabet Med (1994) 0.88
Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care (1998) 0.87
Type 2 diabetes mellitus, impaired glucose tolerance and associated factors in a rural Palestinian village. Diabet Med (2000) 0.87
The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 0.87
Differences in the development of the obese-hyperglycemic syndrome in obob and NZO mice. Diabetologia (1970) 0.87
HLA-DR antigen matching in cadaver renal transplantation. Lancet (1978) 0.86
Reduced glucose transport and increased binding of insulin in adipocytes from diabetic and fasted rats. Biochim Biophys Acta (1978) 0.86
Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost (1993) 0.86
Goodpasture's syndrome. A report of seven patients including long-term follow-up of three who received a kidney transplant. Am J Med (1980) 0.86
A leucine-to-proline mutation in the insulin receptor in a family with insulin resistance. EMBO J (1989) 0.85
Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia (1998) 0.85
Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls. Immunobiology (1984) 0.85
Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients. Diabet Med (1992) 0.85
Repeatability of three-day dietary records in the EURODIAB IDDM Complications Study. Eur J Clin Nutr (1997) 0.85
The surgical approach to the adrenal gland: a comparison of the retroperitoneal and the transabdominal routes in 326 operations on 284 patients. Jpn J Clin Oncol (2000) 0.84
Renal transplantation in insulin-treated diabetics. Transplant Proc (1979) 0.84
The effect of etomoxir on insulin sensitivity in type 2 diabetic patients. Horm Metab Res (1992) 0.84
Influence of HLA-A, -B, -C, and -D matching on the outcome of clinical kidney transplantation. Transplant Proc (1977) 0.83
The effect of insulin, serum and dexamethasone on mRNA levels for the insulin receptor in the human lymphoblastoic cell line IM-9. Biochim Biophys Acta (1987) 0.83
Importance of HLA-DR matching in cadaveric renal transplantation: a prospective one-center study of 170 transplants. N Engl J Med (1980) 0.83
Long-term results of total adrenalectomy for Cushing's disease. World J Surg (2000) 0.83
Diabetes mellitus and pregnancy--management and results at Rikshospitalet, Oslo, 1970-1977. Diabetologia (1979) 0.83
Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes (1995) 0.83
Fibroblasts from a leprechaun patient have defects in insulin binding and insulin receptor autophosphorylation. Diabetologia (1988) 0.82
Endothelin-1 inhibits the adipose differentiation of cultured human adipocyte precursor cells. Metabolism (1994) 0.82
An Arg for Gly substitution at position 31 in the insulin receptor, linked to insulin resistance, inhibits receptor processing and transport. J Biol Chem (1992) 0.82
Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia (1984) 0.82